157 related articles for article (PubMed ID: 37370182)
1. Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study.
Wang J; Li M; Guo P; He D
J Orthop Surg Res; 2023 Jun; 18(1):465. PubMed ID: 37370182
[TBL] [Abstract][Full Text] [Related]
2. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
4. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
5. Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?
Tsuda Y; Tsoi K; Stevenson JD; Parry MC; Fujiwara T; Sumathi V; Jeys LM
Clin Orthop Relat Res; 2020 Jun; 478(6):1190-1198. PubMed ID: 31904683
[TBL] [Abstract][Full Text] [Related]
6. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
7. Definitive surgery of primary lesion should be prioritized over preoperative chemotherapy to treat high-grade osteosarcoma in patients aged 41-65 years.
Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Funauchi Y; Minami Y; Saito M; Okawa A
J Orthop Traumatol; 2020 Aug; 21(1):13. PubMed ID: 32865641
[TBL] [Abstract][Full Text] [Related]
8. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
9. Surgery Has Positive Effects on Spinal Osteosarcoma Prognosis: A Population-Based Database Study.
Tang C; Wang D; Wu Y; Xu H; Zhang H
World Neurosurg; 2022 Aug; 164():e367-e386. PubMed ID: 35504478
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
11. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
12. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.
Wakamatsu T; Kakunaga S; Takenaka S; Outani H; Hamada K; Imura Y; Hori Y; Naka N; Kudawara I; Yoshikawa H; Ueda T
Int J Clin Oncol; 2019 Oct; 24(10):1311-1319. PubMed ID: 31197555
[TBL] [Abstract][Full Text] [Related]
14. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
[TBL] [Abstract][Full Text] [Related]
15. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
[TBL] [Abstract][Full Text] [Related]
16. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and comprehensive treatment of skull base osteosarcoma].
Hu K; Wan J; Ni S; Li X; Liu S; Meng X; Qian H
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):383-6. PubMed ID: 26463032
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
[TBL] [Abstract][Full Text] [Related]
19. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.
Lewis IJ; Nooij MA; Whelan J; Sydes MR; Grimer R; Hogendoorn PC; Memon MA; Weeden S; Uscinska BM; van Glabbeke M; Kirkpatrick A; Hauben EI; Craft AW; Taminiau AH; ;
J Natl Cancer Inst; 2007 Jan; 99(2):112-28. PubMed ID: 17227995
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]